Centiva Capital’s Zimmer Biomet ZBH Stock Holding History

Centiva Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,977	Closed	-$537K	–	2505
2024 Q3	$537K	Sell	4,977 -7,614	-60%	-$831K	0.01%	1208
2024 Q2	$1.37M	Buy	+12,591	New	+$1.48M	0.02%	618
2024 Q1	–	Sell	-2,383	Closed	-$290K	–	2337
2023 Q4	$290K	Sell	2,383 -6,105	-72%	-$681K	0.01%	1222
2023 Q3	$953K	Buy	+8,488	New	+$1.08M	0.02%	669
2023 Q2	–	Sell	-7,730	Closed	-$999K	–	2069
2023 Q1	$999K	Buy	+7,730	New	+$971K	0.02%	619
2022 Q3	–	Sell	-10,074	Closed	-$1.06M	–	1852
2022 Q2	$1.06M	Buy	+10,074	New	+$1.2M	0.03%	586
2022 Q1	–	Sell	-9,504	Closed	-$1.17M	–	1841
2021 Q4	$1.17M	Buy	+9,504	New	+$1.24M	0.02%	563
2020 Q4	–	Sell	-6,042	Closed	-$799K	–	1135
2020 Q3	$799K	Buy	+6,042	New	+$789K	0.05%	245
2020 Q2	–	Sell	-8,966	Closed	-$880K	–	842
2020 Q1	$880K	Buy	8,966 +7,289	+435%	+$955K	0.04%	225
2019 Q4	$244K	Sell	1,677 -2,713	-62%	-$374K	0.01%	614
2019 Q3	$585K	Buy	+4,390	New	+$567K	0.04%	291

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Centiva Capital's ZBH Position: Q4 2024 in Review

Centiva Capital sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 4,977 shares — an estimated $537K sold.

Centiva Capital first reported a position in ZBH in Q3 2019 and held it in 11 quarters. The position peaked at $1.37M in Q2 2024. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

Centiva Capital reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
Centiva Capital sold 4,977 Zimmer Biomet shares in Q4 2024, an estimated $537K.
Centiva Capital first reported a position in Zimmer Biomet in Q3 2019 and held it in 11 quarters.
Centiva Capital's Zimmer Biomet position peaked at $1.37M in Q2 2024.
1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.